CSPG4 and metastatic malignant neoplasm in the lymph nodes: Furthermore, CSPG4 gene expression was measured across primary and metastatic disease (skin, visceral and lymph node metastases) (Fig. 1d, left, n = 36–208), and across all stages of melanoma (Fig. 1d, right).